Viemed Healthcare (VMD) EPS (Weighted Average and Diluted) (2018 - 2026)

Viemed Healthcare has reported EPS (Weighted Average and Diluted) for 9 years, with the latest figure at $0.06 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to $0.06; the trailing twelve-month figure through Mar 2026 stood at $0.37 (up 19.35% YoY), and the FY2025 full-year result was $0.37, up 32.14% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.06, down from $0.14 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $0.14 in Q4 2025, with the low at $0.02 in Q2 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.07 across 5 years, with a median of $0.06 in 2023.
• Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) sank 50.0% — and 2023, when it surged 200.0%.
• Viemed Healthcare's EPS (Weighted Average and Diluted) stood at $0.07 in 2022, then climbed by 14.29% to $0.08 in 2023, then jumped by 37.5% to $0.11 in 2024, then climbed by 27.27% to $0.14 in 2025, then sank by 57.14% to $0.06 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.06 (Q1 2026), $0.14 (Q4 2025), and $0.09 (Q3 2025), per Business Quant data.